Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus after Intravenous Injection

Daniel M. Lipinski, Chris A. Reid, Sanford L. Boye, James J. Peterson, Xiaoping Qi, Shannon E. Boye, Michael E. Boulton, William W. Hauswirth

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The ability to effectively deliver genetic material to vascular endothelial cells remains one of the greatest unmet challenges facing the development of gene therapies to prevent diseases with underlying vascular etiology, such as diabetes, atherosclerosis, and age-related macular degeneration. Herein, we assess the effectiveness of an rAAV2-based capsid mutant vector (Y272F, Y444F, Y500F, Y730F, T491V; termed QuadYF+TV) with strong endothelial cell tropism at transducing the vasculature after systemic administration. Intravenous injection of QuadYF+TV resulted in widespread transduction throughout the vasculature of several major organ systems, as assessed by in vivo bioluminescence imaging and postmortem histology. Robust transduction of lung tissue was observed in QuadYF+TV-injected mice, indicating a role for intravenous gene delivery in the treatment of chronic diseases presenting with pulmonary complications, such as α1-Antitrypsin deficiency. The QuadYF+TV vector cross-reacted strongly with AAV2 neutralizing antibodies, however, indicating that a targeted delivery strategy may be required to maximize clinical translatability.

Original languageEnglish (US)
Pages (from-to)767-776
Number of pages10
JournalHuman Gene Therapy
Volume26
Issue number11
DOIs
StatePublished - Nov 1 2015

Fingerprint

Dependovirus
Capsid
Intravenous Injections
Blood Vessels
Endothelial Cells
Lung
Tropism
Macular Degeneration
Neutralizing Antibodies
Genetic Therapy
Genes
Atherosclerosis
Histology
Chronic Disease
Therapeutics

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Lipinski, D. M., Reid, C. A., Boye, S. L., Peterson, J. J., Qi, X., Boye, S. E., ... Hauswirth, W. W. (2015). Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus after Intravenous Injection. Human Gene Therapy, 26(11), 767-776. https://doi.org/10.1089/hum.2015.097

Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus after Intravenous Injection. / Lipinski, Daniel M.; Reid, Chris A.; Boye, Sanford L.; Peterson, James J.; Qi, Xiaoping; Boye, Shannon E.; Boulton, Michael E.; Hauswirth, William W.

In: Human Gene Therapy, Vol. 26, No. 11, 01.11.2015, p. 767-776.

Research output: Contribution to journalArticle

Lipinski, DM, Reid, CA, Boye, SL, Peterson, JJ, Qi, X, Boye, SE, Boulton, ME & Hauswirth, WW 2015, 'Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus after Intravenous Injection', Human Gene Therapy, vol. 26, no. 11, pp. 767-776. https://doi.org/10.1089/hum.2015.097
Lipinski, Daniel M. ; Reid, Chris A. ; Boye, Sanford L. ; Peterson, James J. ; Qi, Xiaoping ; Boye, Shannon E. ; Boulton, Michael E. ; Hauswirth, William W. / Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus after Intravenous Injection. In: Human Gene Therapy. 2015 ; Vol. 26, No. 11. pp. 767-776.
@article{1c75f9f6cfc64fe997c97dbb2c0c6797,
title = "Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus after Intravenous Injection",
abstract = "The ability to effectively deliver genetic material to vascular endothelial cells remains one of the greatest unmet challenges facing the development of gene therapies to prevent diseases with underlying vascular etiology, such as diabetes, atherosclerosis, and age-related macular degeneration. Herein, we assess the effectiveness of an rAAV2-based capsid mutant vector (Y272F, Y444F, Y500F, Y730F, T491V; termed QuadYF+TV) with strong endothelial cell tropism at transducing the vasculature after systemic administration. Intravenous injection of QuadYF+TV resulted in widespread transduction throughout the vasculature of several major organ systems, as assessed by in vivo bioluminescence imaging and postmortem histology. Robust transduction of lung tissue was observed in QuadYF+TV-injected mice, indicating a role for intravenous gene delivery in the treatment of chronic diseases presenting with pulmonary complications, such as α1-Antitrypsin deficiency. The QuadYF+TV vector cross-reacted strongly with AAV2 neutralizing antibodies, however, indicating that a targeted delivery strategy may be required to maximize clinical translatability.",
author = "Lipinski, {Daniel M.} and Reid, {Chris A.} and Boye, {Sanford L.} and Peterson, {James J.} and Xiaoping Qi and Boye, {Shannon E.} and Boulton, {Michael E.} and Hauswirth, {William W.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1089/hum.2015.097",
language = "English (US)",
volume = "26",
pages = "767--776",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

TY - JOUR

T1 - Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus after Intravenous Injection

AU - Lipinski, Daniel M.

AU - Reid, Chris A.

AU - Boye, Sanford L.

AU - Peterson, James J.

AU - Qi, Xiaoping

AU - Boye, Shannon E.

AU - Boulton, Michael E.

AU - Hauswirth, William W.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - The ability to effectively deliver genetic material to vascular endothelial cells remains one of the greatest unmet challenges facing the development of gene therapies to prevent diseases with underlying vascular etiology, such as diabetes, atherosclerosis, and age-related macular degeneration. Herein, we assess the effectiveness of an rAAV2-based capsid mutant vector (Y272F, Y444F, Y500F, Y730F, T491V; termed QuadYF+TV) with strong endothelial cell tropism at transducing the vasculature after systemic administration. Intravenous injection of QuadYF+TV resulted in widespread transduction throughout the vasculature of several major organ systems, as assessed by in vivo bioluminescence imaging and postmortem histology. Robust transduction of lung tissue was observed in QuadYF+TV-injected mice, indicating a role for intravenous gene delivery in the treatment of chronic diseases presenting with pulmonary complications, such as α1-Antitrypsin deficiency. The QuadYF+TV vector cross-reacted strongly with AAV2 neutralizing antibodies, however, indicating that a targeted delivery strategy may be required to maximize clinical translatability.

AB - The ability to effectively deliver genetic material to vascular endothelial cells remains one of the greatest unmet challenges facing the development of gene therapies to prevent diseases with underlying vascular etiology, such as diabetes, atherosclerosis, and age-related macular degeneration. Herein, we assess the effectiveness of an rAAV2-based capsid mutant vector (Y272F, Y444F, Y500F, Y730F, T491V; termed QuadYF+TV) with strong endothelial cell tropism at transducing the vasculature after systemic administration. Intravenous injection of QuadYF+TV resulted in widespread transduction throughout the vasculature of several major organ systems, as assessed by in vivo bioluminescence imaging and postmortem histology. Robust transduction of lung tissue was observed in QuadYF+TV-injected mice, indicating a role for intravenous gene delivery in the treatment of chronic diseases presenting with pulmonary complications, such as α1-Antitrypsin deficiency. The QuadYF+TV vector cross-reacted strongly with AAV2 neutralizing antibodies, however, indicating that a targeted delivery strategy may be required to maximize clinical translatability.

UR - http://www.scopus.com/inward/record.url?scp=84946906911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946906911&partnerID=8YFLogxK

U2 - 10.1089/hum.2015.097

DO - 10.1089/hum.2015.097

M3 - Article

C2 - 26359319

AN - SCOPUS:84946906911

VL - 26

SP - 767

EP - 776

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 11

ER -